Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Keros Therapeutics (KROS) Shares Issued: 2019-2025

Historic Shares Issued for Keros Therapeutics (KROS) over the last 6 years, with Sep 2025 value amounting to $117,000.

  • Keros Therapeutics' Shares Issued fell 88.39% to $117,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 75.40%. This contributed to the annual value of $12.1 million for FY2024, which is 276.47% up from last year.
  • According to the latest figures from Q3 2025, Keros Therapeutics' Shares Issued is $117,000, which was up 588.24% from $17,000 recorded in Q2 2025.
  • Over the past 5 years, Keros Therapeutics' Shares Issued peaked at $107.3 million during Q1 2023, and registered a low of -$105.2 million during Q2 2023.
  • For the 3-year period, Keros Therapeutics' Shares Issued averaged around $1.4 million, with its median value being $804,000 (2023).
  • Examining YoY changes over the last 5 years, Keros Therapeutics' Shares Issued showed a top increase of 138,434.29% in 2022 and a maximum decrease of 23,511.84% in 2022.
  • Keros Therapeutics' Shares Issued (Quarterly) stood at $245,000 in 2021, then crashed by 23,511.84% to -$57.4 million in 2022, then spiked by 101.40% to $804,000 in 2023, then soared by 204.10% to $2.4 million in 2024, then slumped by 88.39% to $117,000 in 2025.
  • Its Shares Issued stands at $117,000 for Q3 2025, versus $17,000 for Q2 2025 and $4,000 for Q1 2025.